Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Seagen Inc.
Columbia University
Stanford University
Seagen Inc.
Hoffmann-La Roche
City of Hope Medical Center
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Northwestern University
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Novartis
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
University of South Florida
City of Hope Medical Center
City of Hope Medical Center
Seagen Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Columbia University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northside Hospital, Inc.
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
University of Alabama at Birmingham